CAPR Earnings Results and History
Capricor Therapeutics, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- EPS−$0.73
- Revenue–
Filed ยท Press release
Key takeaways
from the press release- Q3 net loss of $42.7M, or $0.73 per share, vs $24.6M or $0.54 a year earlier, as operating expenses rose to $44.7M.
- No revenue recognized; the company remains pre-revenue while Deramiocel awaits FDA action.
Reports and price reactions
last 9 reportsYear by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Dec 31, 2025 | $0 | −100.0% | – | −$105M | −$2.26 |
| Dec 31, 2024 | $22.3M | −11.5% | −191.1% | −$40.5M | −$1.15 |
| Dec 31, 2023 | $25.2M | +886.8% | −95.6% | −$22.3M | −$0.83 |
| Dec 31, 2022 | $2.6M | +941.8% | −1163.9% | −$29M | −$1.18 |
| Dec 31, 2021 | $245K | – | −8549.9% | −$20M | −$0.87 |
Filings and dates
SEC EDGAR- Nov 10, 2026Earnings release, Q3 20268-K Press release
- Nov 10, 2026Quarterly report10-Q All filings
Also see CAPR institutional ownership and the earnings calendar.
CAPR earnings FAQ
What were CAPR's latest earnings?
For Q3 2026 Capricor Therapeutics, Inc. reported, GAAP EPS of -$0.73. The results were filed with the SEC on Nov 10, 2026.
When is CAPR's next earnings date?
There is no confirmed date on our calendar yet. Most companies report about four to six weeks after each quarter ends.
Where do these numbers come from?
Results, guidance and financials come from Capricor Therapeutics, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.